A former commissioner of the Food and Drug Administration and a member of Pfizer’s board of directors, he said on Tuesday that President Donald Trump’s administration had refused to accept millions of additional Pfizer and Bioendech’s corona virus vaccines. Scott Courtlip told CNBC that the White House had turned down “many” offers from Pfizer to sign a deal to get more vaccines in the second quarter of 2021. The New York Times and the Associated Press Months ago The Trump administration locked up the opportunity to buy millions of extra volumes against Govt-19, which has been shown to be very effective against Govt-19. This decision will delay the delivery of the second batch size until Pfizer fulfills other international agreements. “It simply came to our notice then. It has entered into agreements with other countries to sell some of the vaccine in the second quarter of 2021, ”Godlip told CNBC. Trump’s plans to hold a White House summit a week after this revelation aimed at celebrating the expected approval of the first vaccine. His administration seeks to alleviate public skepticism about the vaccine and to protect a key element in the Republican presidency. The focus was on the administration’s plans to distribute and administer the vaccine, but officials from President-elect Joe Biden’s alternative committee will oversee much of the country’s largest vaccination program when he takes office on January 20. Not invited. Pfizer’s vaccine is expected to be approved by the Food and Drug Administration Advisory Board soon this week. At 100 million volumes – enough for 50 million Americans – is expected in the coming months. Under its deal with Pfizer, the Trump administration initially promised to buy 100 million doses, with the option of buying five times as much. But this summer, the White House chose not to lock in an additional 100 million doses to be delivered in the second quarter of 2021, and according to anonymous speakers hey did not have the authority to discuss it publicly. In a statement, Pfizer confirmed the White House’s initial order, but declined to comment on “any possible secret talks with the US government.” However, the company said more than $ 100 million already allocated to the United States would be subject to separate contracts. “Realizing the urgency of the need, our production teams are working around the clock so we can bring the vaccine to the world as quickly, efficiently and equally as possible,” Pfizer said in a statement. Manchef Slawy, who heads the government’s vaccination efforts, said the Trump administration has been looking at various vaccines over the summer. He told the ABC’s “Good Morning America” on Tuesday that “no one will buy a fair amount of any vaccine because we do not know what works and what’s better than another.” Assistant Secretary of Health Brett Giorgio told CBS This Morning that the United States expects about 20 million people to be vaccinated this month, from 20 million to 25 million in January, and 20 million to 25 million in February with another vaccine. Both are considered FDA emergency accreditation by drugmaker Moderna. The Trump administration insists that between those two vaccines and others, it could accommodate any American who wants to be vaccinated by the end of the second quarter of 2021. The New York Times first announced last summer the decision not to lock in additional Pfizer purchases. Management told Health and Human Services Secretary Alex Azhar NBC: “We continue to work to expand the availability of FDA-approved vaccines across manufacturers. We still have that option for 500 million sizes. The “Operation Warp Speed” summit will be attended by Trump, Vice President Mike Pence and a number of government experts, heads of state and business executives. The vaccine is safe and the administration plans to bring it to the American people. Officials from the pharmaceutical companies that make the vaccines were not expected to attend, despite invitations. Some expressed concern about the event to politicize the vaccine development process and further undermine public confidence in drugs. An official who previewed the event said Trump was about to kick the event with comments aimed at “celebrating” vaccine development. Trump will sign an executive order giving Americans priority over the corona virus vaccine purchased by the federal government. A second official said the U.S. government would ban the delivery of the dose to other countries until more supplies were available to meet domestic needs. The two officials spoke anonymously to discuss plans for the summit. Pfizer has a team of vaccine experts from the Food and Drug Administration to meet Thursday to make a final study on the drug, and it will meet with a vaccine later this month in Moderna. The FDA is not required to follow the panel’s advice, although this is usual. Urgent decisions on both drugs are expected within a few days of each meeting. Both have been determined to be 95 percent effective against the virus that causes COVID-19. Plans call for the two companies to distribute and administer about 40 million doses of the vaccine by the end of this year – within the first dose shipment within hours of FDA approval. Biden said Friday that “there is no comprehensive plan that we have seen.” For how to get vaccines from containers, into syringes, and then into people’s hands. Trump executives insist that such programs have been developed, with most tasks falling to state and municipal governments to ensure that their most vulnerable people are vaccinated first. In total, about 50,000 vaccination sites are registered in the government distribution system, officials said. Each upcoming vaccine has unique logistics challenges related to distribution and administration. The Pfizer vaccine must be carried at a supercooled temperature, and comes in 975 doses. Each vial has five sizes, requiring careful planning. Management has produced detailed videos on how to safely prepare and manage the dosages to be released after the FDA issues its Emergency Use Authorization. One such plan is to be announced on Tuesday: Pharmaceutical chains CVS and Walkreens are a “mobile vaccination service” ready to vaccinate people in every nursing home and long-term care facility in the country. More than 3 million people in those facilities are highly vulnerable to Covit-19, and with more than 20 million health workers, they are placed in front of the queue to access the vaccine. So far 80-85 per cent of the facilities have signed up for the service, officials said.
Source